scholarly journals Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2

2018 ◽  
Vol 118 (3) ◽  
pp. 344-352 ◽  
Author(s):  
Rastislav Bahleda ◽  
Andrea Varga ◽  
Yann Bergé ◽  
Jean-Charles Soria ◽  
David Schnell ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumours ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours

2011 ◽  
Vol 30 (5) ◽  
pp. 1962-1971 ◽  
Author(s):  
Tanja Trarbach ◽  
Beate Schultheis ◽  
Thomas C. Gauler ◽  
Vesile Schneider ◽  
Dirk Strumberg ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumours ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Src Inhibitor ◽  
Vegf Signalling

scholarly journals A phase I, open-label study of GSK1795091 administered in combination with immunotherapies in participants with advanced solid tumours (NCT03447314)

2019 ◽  
Vol 30 ◽  
pp. v192-v193
Author(s):  
A.R. Hansen ◽  
J. Strauss ◽  
J. Chaves ◽  
S.A. Piha-Paul ◽  
H. Park ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumours ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Open‐label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment

2019 ◽  
Vol 85 (6) ◽  
pp. 1239-1246 ◽  
Author(s):  
Muhammad Wasif Saif ◽  
Lee Rosen ◽  
Michelle A. Rudek ◽  
Weijing Sun ◽  
Dale R. Shepard ◽  
...  
Keyword(s):  
Hepatic Impairment ◽  
Solid Tumours ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

A phase I open-label study investigating the disposition of [14C]-cabazitaxel in patients with advanced solid tumors

2015 ◽  
Vol 26 (3) ◽  
pp. 350-358 ◽  
Author(s):  
Laurence Ridoux ◽  
Dorothée R. Sémiond ◽  
Carine Vincent ◽  
Hélène Fontaine ◽  
Christine Mauriac ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

A phase I, open-label study of the safety, tolerability and pharmacokinetics of lapatinib (GW572016) in combination with letrozole in cancer patients

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3001-3001 ◽  
Author(s):  
Q. Chu ◽  
L. Goldstein ◽  
N. Murray ◽  
E. Rowinsky ◽  
M. Cianfrocca ◽  
...  
Keyword(s):  
Phase I ◽  
Cancer Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document